Company Overview and News

 
Elixir in Golden buy

2017-10-17 businessnews.com.au
Perth-based explorer Elixir Petroleum has entered into an agreement to acquire a Mongolia-focused coal seam gas business in an all-scrip deal worth about $4 million.
Upvote Downvote

 
Elixir Petroleum to reveal raising, proposed transaction

2017-10-12 proactiveinvestors.com.au
Elixir Petroleum Ltd (ASX:EXR) might be on the lookout for a new asset, as the ASX has granted the company a trading halt pending details of a proposed transaction.
Upvote Downvote

 
Elixir Petroleum Ltd granted ASX trading halt

2016-07-08 proactiveinvestors.com.au
Elixir Petroleum Ltd (ASX:EXR) has been granted a trading halt by the ASX, with its shares placed in pre-open. Elixir requested the halt pending details of a capital raising, proposed consolidation and rights issue. The halt will remain in place until the opening of trade on Tuesday 12th July 2016, or earlier of an announcement is mad to the market.
Upvote Downvote

 
Triangle Energy Buys Cliff Head Oil Field Offshore Perth Basin for $2.4M

2016-06-21 rigzone
Triangle Energy (Global) Ltd., a junior exploration and production firm in Australia, purchased a 57.5 percent interest in Cliff Head oil field in permit WA-31-L in the Perth Basin, offshore Western Australia, from AWE Ltd. for an upfront acquisition cost of $2.4 million (AUD 3.21 million) plus a future royalty of $5 a barrel for oil sales above $70 a barrel.
Upvote Downvote

 
AWE snubs Elixir, finds new buyer for Cliff Head

2016-06-16 businessnews.com.au
Oil and gas company AWE has backed out of plans to offload its majority stake in the Cliff Head offshore oil project to Elixir Petroleum, instead entering into an agreement with an undisclosed buyer.
Upvote Downvote

 
AWE Scraps Plans to Sell Cliff Head Oil Field in WA's Perth Basin to Elixir

2016-06-16 rigzone
AWE Ltd. informed Elixir Petroleum Ltd. Thursday that the proposed sale of a 57.5 percent working interest in the Cliff Head oil field in the Perth Basin, Western Australia would not proceed after the firm agreed to dispose of the stake to a third party.
Upvote Downvote

 
Elixir Petroleum Ltd is ASX % Gainer intra-day

2016-06-08 proactiveinvestors.com.au
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.
Upvote Downvote

 
Elixir Petroleum Ltd among ASX % Gainers intra-day

2016-05-06 proactiveinvestors.com.au
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.
Upvote Downvote

 
 
 
Elixir Continues Talks to Acquire 57.5% Stake in WA's Cliff Head Oil Field

2016-03-16 rigzone
Elixir Petroleum Limited, a Perth-based oil and gas exploration firm with operations in the U.S. and France, announced Wednesday that the company and AWE Limited (the Parties) continue to work towards execution of an agreement for Elixir to acquire a 57.5 percent Working Interest in the producing Cliff Head oil field located in the Perth Basin, offshore Western Australia (Acquisition).
Upvote Downvote

 
 

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

12h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...